dual PPAR gamma/RXR alpha activators (Torrey Pines)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Namedual PPAR gamma/RXR alpha activators (Torrey Pines)

Drug Alias NameCPG-4109

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPeroxisome proliferator-activated receptor γ agonistsRetinoid X receptor alpha agonistsTumor necrosis factor ligand superfamily member 11 inhibitors

TargetsRetinoid X receptor alphaTumor necrosis factor ligand superfamily member 11Peroxisome proliferator-activated receptor γ

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTorrey Pines Institute For Molecular Studies

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTorrey Pines Institute For Molecular Studies

Active IndicationsN/A

Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A